The DOI matches its Crossref record; 12 of the 12 references it cites were found in a registry or an index.
Preoperative platelet lymphocyte ratio (PLR) is superior to neutrophil lymphocyte ratio (NLR) as a predictive factor in patients with esophageal squamous cell carcinoma
Open accessAbstract
BACKGROUND: Recent studies have shown that the presence of systemic inflammation correlates with poor survival in various cancers. The aim of this study was to determinate the prognostic value of the neutrophil lymphocyte ratio (NLR) and the platelet lymphocyte ratio (PLR) in patients with esophageal squamous cell carcinoma (ESCC). METHODS: Preoperative NLR and PLR were evaluated in 483 patients undergoing esophagectomy for ESCC from January 2005 to December 2008. The prognostic significance of both markers was then determined by both uni- and multivariate analytical methods. Receiver operating characteristic (ROC) curves were also plotted to verify the accuracy of NLR and PLR for survival prediction. RESULTS: High preoperative NLR (≥3.5 versus < 3.5, P = 0.039) and PLR (≥150 versus < 150, P < 0.001) were significantly associated with poor overall survival in multivariate analysis. However, our study demonstrated a better discrimination for the PLR in terms of hazard ratio(HR) than the NLR (HR = 1.840 versus HR = 1.339). Patients with NLR ≥3.5 had significantly poorer overall survival compared to NLR <3.5 (35.4% versus 57.7%, P < 0.001). Patients with PLR ≥150 also had significantly poorer overall survival compared to patients with PLR <150 (32.7% versus 63.5%, P < 0.001). The area under the curve (AUC) was 0.658 (95% confidence interval (CI): 0.610 to 0.706, P < 0.001) for NLR and 0.708 (95% CI: 0.662 to 0.754, P < 0.001) for PLR, indicating that PLR was superior to NLR as a predictive factor in ESCC. CONCLUSIONS: Preoperative NLR and PLR were significant predictors of overall survival in patients with ESCC. However, PLR is superior to NLR as a predictive factor in patients with ESCC.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Mantovani, A., Allavena, P., Sica, A., & Balkwill, F. (2008) · Nature · doi:10.1038/nature07205 · Cited by 11,399
Inflammation and cancer: back to Virchow?
Balkwill, F., & Mantovani, A. (2001) · The Lancet · doi:10.1016/s0140-6736(00)04046-0 · Cited by 7,746
Roxburgh, C. S., & McMillan, D. C. (2010) · Future Oncology · doi:10.2217/fon.09.136 · Cited by 998
Kusumanto, Y. H., Dam, W. A., Hospers, G. A. P., Meijer, C., & Mulder, N. H. (2003) · Angiogenesis · doi:10.1023/b:agen.0000029415.62384.ba · Cited by 530
Review: Role of Blood Platelets in Infection and Inflammation
Klinger, M. H. F., & Jelkmann, W. (2002) · Journal of Interferon & Cytokine Research · doi:10.1089/10799900260286623 · Cited by 505
Bhatti, I., Peacock, O., Lloyd, G., Larvin, M., & Hall, R. I. (2010) · The American Journal of Surgery · doi:10.1016/j.amjsurg.2009.08.041 · Cited by 333
Sharaiha, R. Z., Halazun, K. J., Mirza, F., Port, J. L., Lee, P. C., Neugut, A. I., Altorki, N. K., & Abrams, J. A. (2011) · Annals of Surgical Oncology · doi:10.1245/s10434-011-1754-8 · Cited by 325
Zhao, P., Dai, M., Chen, W., & Li, N. (2010) · Japanese Journal of Clinical Oncology · doi:10.1093/jjco/hyp187 · Cited by 296
Corley, D. A., & Buffler, P. A. (2001) · International Journal of Epidemiology · doi:10.1093/ije/30.6.1415 · Cited by 233
Sato, H., Tsubosa, Y., & Kawano, T. (2012) · World Journal of Surgery · doi:10.1007/s00268-011-1411-1 · Cited by 172
Cited by
Qin, B., Ma, N., Tang, Q., Wei, T., Yang, M., Fu, H., Hu, Z., Liang, Y., Yang, Z., & Zhong, R. (2016) · Modern Rheumatology · doi:10.3109/14397595.2015.1091136 · Cited by 452
Yodying, H., Matsuda, A., Miyashita, M., Matsumoto, S., Sakurazawa, N., Yamada, M., & Uchida, E. (2016) · Annals of Surgical Oncology · doi:10.1245/s10434-015-4869-5 · Cited by 386
Liu, J., Li, S., Zhang, S., Liu, Y., Ma, L., Zhu, J., Xin, Y., Wang, Y., Yang, C., & Cheng, Y. (2019) · Journal of Clinical Laboratory Analysis · doi:10.1002/jcla.22964 · Cited by 364
Dolan, R. D., Lim, J., McSorley, S. T., Horgan, P. G., & McMillan, D. C. (2017) · Scientific Reports · doi:10.1038/s41598-017-16955-5 · Cited by 300
Yamagishi, T., Fujimoto, N., Nishi, H., Miyamoto, Y., Hara, N., Asano, M., Fuchimoto, Y., Wada, S., Kitamura, K., Ozaki, S., et al. (2015) · Lung Cancer · doi:10.1016/j.lungcan.2015.07.014 · Cited by 61
Metadata
- Authors
- Feng, J.-F., Huang, Y., & Chen, Q.-X.
- Venue
- World Journal of Surgical Oncology
- Published
- 2014
- Volume
- 12
- Issue
- 1
- Pages
- 58
- ISSN
- 1477-7819 (ISSN-L)
- OpenAlex
- W2147212677
- Cited by
- 267
- References
- 12
- FWCI
- 11.49
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Preoperative platelet lymphocyte ratio (PLR) is superior to neutrophil lymphocyte ratio (NLR) as a predictive factor in patients with esophageal squamous cell carcinoma. https://app.cochat.ai/papers/10.1186/1477-7819-12-58
- The paper
- Feng, J.-F., Huang, Y., & Chen, Q.-X. (2014). Preoperative platelet lymphocyte ratio (PLR) is superior to neutrophil lymphocyte ratio (NLR) as a predictive factor in patients with esophageal squamous cell carcinoma. World Journal of Surgical Oncology. https://doi.org/10.1186/1477-7819-12-58
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.